OBJECTIVE: To investigate the effect of high dose vitamin A supplementation given with BCG vaccine at birth in an African setting with high infant mortality. DESIGN: Randomised placebo controlled trial. Setting Bandim Health Project's demographic surveillance system in Guinea-Bissau, covering approximately 90,000 inhabitants. Participants 4345 infants due to receive BCG. INTERVENTION: Infants were randomised to 50,000 IU vitamin A or placebo and followed until age 12 months. MAIN OUTCOME MEASURE: Mortality rate ratios. RESULTS:174 children died during follow-up (mortality=47/1000 person-years). Vitamin A supplementation was not significantly associated with mortality; the mortality rate ratio was 1.07 (95% confidence interval 0.79 to 1.44). The effect was 1.00 (0.65 to 1.56) during the first four months and 1.13 (0.75 to 1.68) from 4 to 12 months of age. The mortality rate ratio in boys was 0.84 (0.55 to 1.27) compared with 1.39 (0.90 to 2.14) in girls (P for interaction=0.10). An explorative analysis revealed a strong interaction between vitamin A and season of administration. CONCLUSIONS:Vitamin A supplementation given with BCG vaccine at birth had no significant benefit in this African setting. Although little doubt exists that vitamin A supplementation reduces mortality in older children, a global recommendation of supplementation for all newborn infants may not contribute to better survival. TRIAL REGISTRATION: Clinical trials NCT00168597.
RCT Entities:
OBJECTIVE: To investigate the effect of high dose vitamin A supplementation given with BCG vaccine at birth in an African setting with high infant mortality. DESIGN: Randomised placebo controlled trial. Setting Bandim Health Project's demographic surveillance system in Guinea-Bissau, covering approximately 90,000 inhabitants. Participants 4345 infants due to receive BCG. INTERVENTION: Infants were randomised to 50,000 IU vitamin A or placebo and followed until age 12 months. MAIN OUTCOME MEASURE: Mortality rate ratios. RESULTS: 174 children died during follow-up (mortality=47/1000 person-years). Vitamin A supplementation was not significantly associated with mortality; the mortality rate ratio was 1.07 (95% confidence interval 0.79 to 1.44). The effect was 1.00 (0.65 to 1.56) during the first four months and 1.13 (0.75 to 1.68) from 4 to 12 months of age. The mortality rate ratio in boys was 0.84 (0.55 to 1.27) compared with 1.39 (0.90 to 2.14) in girls (P for interaction=0.10). An explorative analysis revealed a strong interaction between vitamin A and season of administration. CONCLUSIONS:Vitamin A supplementation given with BCG vaccine at birth had no significant benefit in this African setting. Although little doubt exists that vitamin A supplementation reduces mortality in older children, a global recommendation of supplementation for all newborn infants may not contribute to better survival. TRIAL REGISTRATION: Clinical trials NCT00168597.
Authors: K P West; S C LeClerq; S R Shrestha; L S Wu; E K Pradhan; S K Khatry; J Katz; R Adhikari; A Sommer Journal: J Nutr Date: 1997-10 Impact factor: 4.798
Authors: Lucie C Malaba; Peter J Iliff; Kusum J Nathoo; Edmore Marinda; Lawrence H Moulton; Lynn S Zijenah; Partson Zvandasara; Brian J Ward; Jean H Humphrey Journal: Am J Clin Nutr Date: 2005-02 Impact factor: 7.045
Authors: D A Ross; B R Kirkwood; F N Binka; P Arthur; N Dollimore; S S Morris; R P Shier; J O Gyapong; P G Smith Journal: Am J Public Health Date: 1995-09 Impact factor: 9.308
Authors: J H Humphrey; T Agoestina; L Wu; A Usman; M Nurachim; D Subardja; S Hidayat; J Tielsch; K P West; A Sommer Journal: J Pediatr Date: 1996-04 Impact factor: 4.406
Authors: Daniel J Raiten; Fayrouz A Sakr Ashour; A Catharine Ross; Simin N Meydani; Harry D Dawson; Charles B Stephensen; Bernard J Brabin; Parminder S Suchdev; Ben van Ommen Journal: J Nutr Date: 2015-04-01 Impact factor: 4.798
Authors: Erliyani Sartono; Ida M Lisse; Elisabeth M Terveer; Paula J M van de Sande; Hilton Whittle; Ane B Fisker; Adam Roth; Peter Aaby; Maria Yazdanbakhsh; Christine S Benn Journal: PLoS One Date: 2010-05-21 Impact factor: 3.240
Authors: Peter Aaby; Cesário L Martins; May-Lill Garly; Carlito Balé; Andreas Andersen; Amabelia Rodrigues; Henrik Ravn; Ida M Lisse; Christine S Benn; Hilton C Whittle Journal: BMJ Date: 2010-11-30
Authors: Adam Edvin Roth; Christine Stabell Benn; Henrik Ravn; Amabelia Rodrigues; Ida Maria Lisse; Maria Yazdanbakhsh; Hilton Whittle; Peter Aaby Journal: BMJ Date: 2010-03-15